These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21658592)

  • 1. Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin.
    Vindeløv SD; Hartoft-Nielsen ML; Rasmussen ÅK; Bendtzen K; Kosteljanetz M; Andersson AM; Feldt-Rasmussen U
    Growth Horm IGF Res; 2011 Jun; 21(3):134-9. PubMed ID: 21658592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
    Szalontay L; Benveniste RJ; Schally AV; Vidaurre I; Nadji M; Zarandi M; Block NL; Kovacs M
    Neuroendocrinology; 2012; 96(1):81-8. PubMed ID: 22377963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential contribution of nitric oxide and cGMP to the stimulatory effects of growth hormone-releasing hormone and low-concentration somatostatin on growth hormone release from somatotrophs.
    Luque RM; Rodríguez-Pacheco F; Tena-Sempere M; Gracia-Navarro F; Malagón MM; Castaño JP
    J Neuroendocrinol; 2005 Sep; 17(9):577-82. PubMed ID: 16101896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
    Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
    Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
    Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro.
    Webb CB; Thominet JL; Frohman LA
    J Clin Endocrinol Metab; 1983 Feb; 56(2):417-9. PubMed ID: 6130102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
    Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
    Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
    J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion.
    Serri O
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas.
    Thiele JO; Lohrer P; Schaaf L; Feirer M; Stummer W; Losa M; Lange M; Tichomirowa M; Arzt E; Stalla GK; Renner U
    Eur J Endocrinol; 2003 Nov; 149(5):455-61. PubMed ID: 14585094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
    Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
    Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester, not growth hormone releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture.
    Emoto N; Ohmura E; Isozaki O; Tsushima T; Shizume K; Demura H
    Clin Endocrinol (Oxf); 1991 May; 34(5):377-82. PubMed ID: 2060147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium ion responses to somatostatin in cells from human somatotroph adenomas.
    Chen ZP; Xu S; Lightman SL; Hall L; Levy A
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):45-53. PubMed ID: 9059557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures.
    Sauer J; Renner U; Hopfner U; Lange M; Müller A; Strasburger CJ; Pagotto U; Arzt E; Stalla GK
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2429-34. PubMed ID: 9661623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas.
    Asa SL
    Pathol Res Pract; 1991 Jun; 187(5):581-3. PubMed ID: 1923953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
    Kawakita S; Asa SL; Kovacs K
    J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.